Juan Wisnivesky
Annals of Global Health · 2003–2023
A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Who trusts Juan Wisnivesky overall
Papers from Juan Wisnivesky's perspective
Ordered by how strongly the researchers Juan Wisnivesky trusts endorse each paper. Same corpus, a different order for every researcher.
- The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends (Journal of Thoracic Oncology)
- Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases (Modern Pathology)
- Pathology of lung cancer. (Clinics in Chest Medicine)
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
- GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]
- SEER Cancer Statistics Review, 1975-2003
- A review of human carcinogens--Part B: biological agents. (The Lancet Oncology)
- Recent patterns in gastric cancer: A global overview (International Journal of Cancer)
- The Effect of Advances in Lung-Cancer Treatment on Population Mortality (New England Journal of Medicine)
- Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. (New England Journal of Medicine)
Their papers
- Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. (2023) — 670 citations
- The global burden of lung cancer: current status and future trends (2023) — 1,273 citations
- Global Epidemiology of Lung Cancer (2019) — 1,356 citations
- Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. (2018)
- Medical errors related to discontinuity of care from an inpatient to an outpatient setting (2003) — 795 citations